JBIO
Jade Biosciences Inc

613
Mkt Cap
$737.91M
Volume
379,047.00
52W High
$100.10
52W Low
$6.57
PE Ratio
-1.41
JBIO Fundamentals
Price
$15.68
Prev Close
$16.04
Open
$16.19
50D MA
$11.05
Beta
-1.15
Avg. Volume
227,177.21
EPS (Annual)
-$85.26
P/B
2.92
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Jade Biosciences (NASDAQ:JBIO) Trading 7.4% Higher - Here's What Happened
Jade Biosciences (NASDAQ:JBIO) Stock Price Up 7.4% - Time to Buy...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
Jade Biosciences (NASDAQ:JBIO) Sees Large Volume Increase - Here's What Happened
Jade Biosciences (NASDAQ:JBIO) Sees Large Volume Increase - Should You Buy...
MarketBeat·11d ago
News Placeholder
Geode Capital Management LLC Purchases Shares of 676,431 Jade Biosciences, Inc. $JBIO
Geode Capital Management LLC acquired a new position in shares of Jade Biosciences, Inc. (NASDAQ:JBIO - Free Report) during the 2nd quarter, according to its most recent disclosure with the...
MarketBeat·12d ago
News Placeholder
Does Jade Biosciences, Inc. (JBIO) Have the Potential to Rally 65% as Wall Street Analysts Expect?
The mean of analysts' price targets for Jade Biosciences, Inc. (JBIO) points to a 65% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks·13d ago
News Placeholder
Jade Biosciences, Inc. (NASDAQ:JBIO) Receives Average Rating of "Moderate Buy" from Analysts
Shares of Jade Biosciences, Inc. (NASDAQ:JBIO - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the five ratings firms that are covering the stock, MarketBeat.com...
MarketBeat·19d ago
News Placeholder
Jade Biosciences (NASDAQ:JBIO) Price Target Raised to $17.00 at Guggenheim
Guggenheim upped their price target on Jade Biosciences from $14.00 to $17.00 and gave the company a "buy" rating in a report on Tuesday...
MarketBeat·28d ago
News Placeholder
What Makes Jade Biosciences, Inc. (JBIO) a New Buy Stock
Jade Biosciences, Inc. (JBIO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks·29d ago
News Placeholder
Wall Street Analysts Predict a 52.5% Upside in Jade Biosciences, Inc. (JBIO): Here's What You Should Know
The mean of analysts' price targets for Jade Biosciences, Inc. (JBIO) points to a 52.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks·29d ago
News Placeholder
Jade Biosciences (NASDAQ:JBIO) Posts Earnings Results, Beats Estimates By $0.09 EPS
Jade Biosciences (NASDAQ:JBIO - Get Free Report) released its quarterly earnings results on Thursday. The company reported ($0.48) earnings per share for the quarter, topping analysts' consensus...
MarketBeat·1mo ago
News Placeholder
Noteworthy Monday Option Activity: JBIO, MU, GOOGL
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Jade Biosciences Inc. (Symbol: JBIO), where a total volume of 2,000 contracts has...
Nasdaq News: Markets·1mo ago
<
1
2
...
>

Latest JBIO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.